| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 147, Issue 12 4094-4102, Copyright © 1991 by American Association of Immunologists
ARTICLES |
GS Kansas and TF Tedder
Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, MA 02115-6084.
Transmembrane signals generated following mAb binding to CD19, CD20, CD39, CD40, CD43, Leu-13 Ag, and HLA-D region gene products induced rapid and strong homotypic adhesion in a panel of human B cell lines. Lower levels of adhesion were also observed after engagement of CD21, CD22, and CD23. Adhesion induced by mAb binding to these Ag was identical with respect to the kinetics of adhesion and the morphology of the resulting cellular aggregates, and was distinct from PMA-induced adhesion in both of these properties. Adhesion was not observed in response to mAb binding to MHC class I, CD24, CD38, CD44, CD45RA, or CD72. In contrast to B cell lines, homotypic adhesion was not induced in two pre-B cell lines, in spite of their high level expression of CD19 and HLA-D. Adhesion induced by suboptimal stimulation through these surface Ag or by PMA was mediated primarily through LFA-1 and ICAM-1. However, optimal stimulation through CD19, CD20, CD39, CD40, and HLA-D induced strong homotypic adhesion that was not blocked by anti-LFA-1 mAb. This alternate pathway of adhesion was also observed in LFA-1-deficient cell lines and in the presence of EDTA, suggesting that adhesion was not mediated by integrins. Adhesion in response to engagement of cell-surface Ag was unaffected by H7 or genestein, but was significantly inhibited by staurosporine, and was completely ablated by sphingosine and herbimycin. These studies indicate that engagement of multiple B cell-surface molecules initiates a signal transduction cascade that involves tyrosine kinases but not protein kinase C, and which leads to homotypic adhesion. Furthermore, adhesion was mediated by at least two distinct cell-surface adhesion receptors: LFA-1/ICAM-1 and a heretofore unknown adhesion receptor.
This article has been cited by other articles:
|
|
 |
|
  E. O. Lobo, Z. Zhang, and J. E. Shively Pivotal Advance: CEACAM1 is a negative coreceptor for the B cell receptor and promotes CD19-mediated adhesion of B cells in a PI3K-dependent manner J. Leukoc. Biol., August 1, 2009; 86(2): 205 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Martin, J. Roy, C. Barat, M. Ouellet, C. Gilbert, and M. J. Tremblay Human Immunodeficiency Virus Type 1-Associated CD40 Ligand Transactivates B Lymphocytes and Promotes Infection of CD4+ T Cells J. Virol., June 1, 2007; 81(11): 5872 - 5881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. M. Kunzli, P. O. Berberat, T. Giese, E. Csizmadia, E. Kaczmarek, C. Baker, I. Halaceli, M. W. Buchler, H. Friess, and S. C. Robson Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G223 - G230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Yazawa, Y. Hamaguchi, J. C. Poe, and T. F. Tedder Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease PNAS, October 18, 2005; 102(42): 15178 - 15183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Li, L. M. Ayer, M. J. Polyak, C. M. Mutch, R. J. Petrie, L. Gauthier, N. Shariat, M. J. Hendzel, A. R. Shaw, K. D. Patel, et al. The CD20 Calcium Channel Is Localized to Microvilli and Constitutively Associated with Membrane Rafts: ANTIBODY BINDING INCREASES THE AFFINITY OF THE ASSOCIATION THROUGH AN EPITOPE-DEPENDENT CROSS-LINKING-INDEPENDENT MECHANISM J. Biol. Chem., May 7, 2004; 279(19): 19893 - 19901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Gopal, J. M. Pagel, N. Hedin, and O. W. Press Fenretinide enhances rituximab-induced cytotoxicity against B-cell lymphoma xenografts through a caspase-dependent mechanism Blood, May 1, 2004; 103(9): 3516 - 3520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Stein, Z. Qu, S. Chen, A. Rosario, V. Shi, M. Hayes, I. D. Horak, H. J. Hansen, and D. M. Goldenberg Characterization of a New Humanized Anti-CD20 Monoclonal Antibody, IMMU-106, and Its Use in Combination with the Humanized Anti-CD22 Antibody, Epratuzumab, for the Therapy of Non-Hodgkin's Lymphoma Clin. Cancer Res., April 15, 2004; 10(8): 2868 - 2878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Uchida, Y. Lee, M. Hasegawa, Y. Liang, A. Bradney, J. A. Oliver, K. Bowen, D. A. Steeber, K. M. Haas, J. C. Poe, et al. Mouse CD20 expression and function Int. Immunol., January 1, 2004; 16(1): 119 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. T. C. Chan, D. Hughes, R. R. French, A. L. Tutt, C. A. Walshe, J. L. Teeling, M. J. Glennie, and M. S. Cragg CD20-induced Lymphoma Cell Death Is Independent of Both Caspases and Its Redistribution into Triton X-100 Insoluble Membrane Rafts Cancer Res., September 1, 2003; 63(17): 5480 - 5489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rossbacher and M. J. Shlomchik The B Cell Receptor Itself Can Activate Complement to Provide the Complement Receptor 1/2 Ligand Required to Enhance B Cell Immune Responses In Vivo J. Exp. Med., August 18, 2003; 198(4): 591 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bouillon, Y. El Fakhry, J. Girouard, H. Khalil, J. Thibodeau, and W. Mourad Lipid Raft-dependent and -independent Signaling through HLA-DR Molecules J. Biol. Chem., February 21, 2003; 278(9): 7099 - 7107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fujimoto, J. C. Poe, A. B. Satterthwaite, M. I. Wahl, O. N. Witte, and T. F. Tedder Complementary Roles for CD19 and Bruton's Tyrosine Kinase in B Lymphocyte Signal Transduction J. Immunol., June 1, 2002; 168(11): 5465 - 5476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Polyak and J. P. Deans Alanine-170 and proline-172 are critical determinants for extracellular CD20 epitopes; heterogeneity in the fine specificity of CD20 monoclonal antibodies is defined by additional requirements imposed by both amino acid sequence and quaternary structure Blood, May 1, 2002; 99(9): 3256 - 3262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Wagner Jr., G. Vaitaitis, R. Sanderson, M. Poulin, C. Dobbs, and K. Haskins Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes PNAS, March 19, 2002; 99(6): 3782 - 3787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Roucard, C. Thomas, M.-A. Pasquier, J. Trowsdale, J.-J. Sotto, J. Neefjes, and M. van Ham In Vivo and In Vitro Modulation of HLA-DM and HLA-DO Is Induced by B Lymphocyte Activation J. Immunol., December 15, 2001; 167(12): 6849 - 6858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Mehl, M. Jones, M. Rowe, and P. Brennan Characterization of a CD40-Dominant Inhibitory Receptor Mutant J. Immunol., December 1, 2001; 167(11): 6388 - 6393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Matsuoka, H. Tabata, and S. Matsushita Monocytes Are Differentially Activated Through HLA-DR, -DQ, and -DP Molecules Via Mitogen-Activated Protein Kinases J. Immunol., February 15, 2001; 166(4): 2202 - 2208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Airas, J. Niemela, and S. Jalkanen CD73 Engagement Promotes Lymphocyte Binding to Endothelial Cells Via a Lymphocyte Function-Associated Antigen-1-Dependent Mechanism J. Immunol., November 15, 2000; 165(10): 5411 - 5417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Bobbitt and L. B. Justement Regulation of MHC Class II Signal Transduction by the B Cell Coreceptors CD19 and CD22 J. Immunol., November 15, 2000; 165(10): 5588 - 5596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. J. Huby, R. J. Dearman, and I. Kimber Intracellular Phosphotyrosine Induction by Major Histocompatibility Complex Class II Requires Co-aggregation with Membrane Rafts J. Biol. Chem., August 6, 1999; 274(32): 22591 - 22596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Leveille, H. Zekki, R. Al-Daccak, and W. Mourad CD40- and HLA-DR-mediated cell death pathways share a lot of similarities but differ in their use of ADP-ribosyltransferase activities Int. Immunol., May 1, 1999; 11(5): 719 - 730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tu, M. D. Delahunty, H. Ding, F. W. Luscinskas, and T. F. Tedder The Cutaneous Lymphocyte Antigen Is an Essential Component of the L-selectin Ligand Induced on Human Vascular Endothelial Cells J. Exp. Med., January 18, 1999; 189(2): 241 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sembries, H. Pahl, S. Stilgenbauer, H. Dohner, and F. Schriever Reduced Expression of Adhesion Molecules and Cell Signaling Receptors by Chronic Lymphocytic Leukemia Cells With 11q Deletion Blood, January 15, 1999; 93(2): 624 - 631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Fehr, R. C. Rickert, B. Odermatt, J. Roes, K. Rajewsky, H. Hengartner, and R. M. Zinkernagel Antiviral Protection and Germinal Center Formation, But Impaired B Cell Memory in the Absence of CD19 J. Exp. Med., July 1, 1998; 188(1): 145 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Greer, J. Lin, C. H. Clarke, and L. B. Justement Major Histocompatibility Class II-mediated Signal Transduction Is Regulated by the Protein-tyrosine Phosphatase CD45 J. Biol. Chem., May 8, 1998; 273(19): 11970 - 11979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Makar, C. T. N. Pham, M. H. Dehoff, S. M. O'Connor, S. M. Jacobi, and V. M. Holers An Intronic Silencer Regulates B Lymphocyte Cell- and Stage-Specific Expression of the Human Complement Receptor Type 2 (CR2, CD21) Gene J. Immunol., February 1, 1998; 160(3): 1268 - 1278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Sarma, Z. Lin, L. Clark, B. M. Rust, M. Tewari, R. J. Noelle, and V. M. Dixit Activation of the B-cell Surface Receptor CD40 Induces A20, a Novel Zinc Finger Protein That Inhibits Apoptosis J. Biol. Chem., May 26, 1995; 270(21): 12343 - 12346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Weitzman, A Chen, and M. Hemler Investigation of the role of beta 1 integrins in cell-cell adhesion J. Cell Sci., January 11, 1995; 108(11): 3635 - 3644. [Abstract] [PDF]
|
|
|
|
|
|
H. Tabata, T. Matsuoka, F. Endo, Y. Nishimura, and S. Matsushita Ligation of HLA-DR Molecules on B Cells Induces Enhanced Expression of IgM Heavy Chain Genes in Association with Syk Activation J. Biol. Chem., November 3, 2000; 275(45): 34998 - 35005. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
